Looking for something specific?
At 9M India Limited, trust through quality, transparency, performance.
Anti-Inflammatory Eye Drop Manufacturer in India
WHO-GMP certified sterile manufacturing of anti-inflammatory ophthalmic preparations — corticosteroid and NSAID eye drops — for post-operative inflammation, uveitis and ocular inflammatory conditions.
Key Highlights
-
WHO-GMP
Certified Sterile Ophthalmic Facility -
Sterile Cleanroom
· Grade A/B Manufacturing -
DCGI Approved
Formulations -
Export-Ready
What We Manufacture
Our Anti-Inflammatory Ophthalmic eye drop range
Anti-inflammatory eye drops are essential in post-operative ophthalmic care and management of ocular inflammatory disease.
Key molecules manufactured:
- Prednisolone Acetate 1% Eye Drops (Suspension) — Gold standard for post-operative inflammation after cataract surgery
- Dexamethasone 0.1% Eye Drops — Corticosteroid for anterior segment inflammation
- Dexamethasone 0.1% + Tobramycin 0.3% Eye Drops — Combination for post-surgical infection and inflammation
- Fluorometholone 0.1% · 0.25% Eye Drops — Lower IOP-raising risk corticosteroid for chronic use
- Ketorolac 0.4% · 0.5% Eye Drops — NSAID for post-cataract pain and inflammation
- Nepafenac 0.1% · 0.3% Eye Drops (Suspension) — NSAID prodrug for cataract surgery
- Bromfenac 0.09% · 0.07% Eye Drops — Long-acting NSAID for twice-daily dosing post-cataract
Enquire Now
WHY 9M INDIA
Post-surgical ophthalmic anti-inflammatory manufacturing with suspension stability expertise
-
Sterile ophthalmic manufacturing — classified cleanroom
All ophthalmic preparations at 9M India are manufactured in dedicated sterile cleanroom environments — Grade A fill-finish under Class A laminar airflow, with Grade B background. Environmental monitoring, water for injection (WFI) system validation, 0.22 micron sterile filtration and 100% container closure integrity testing are standard on every batch. No ophthalmic product is manufactured outside these conditions.
-
In-house ophthalmic QC — specialised testing
Sterility · Bacterial endotoxins · Visible particulate matter · Sub-visible particles · pH · Osmolality · Assay (HPLC) · Preservative content · Container closure integrity — all tested in our dedicated ophthalmic QC laboratory. COA issued per batch.
-
Complete documentation within 24 hours
DCGI manufacturing licence · WHO-GMP Certificate · COA · COC · Stability data (ICH Zone II and IVa) · Compatibility studies — available within 24 hours for tender, export registration or CDMO requirements.
WHO WE SUPPLY
Who sources anti-inflammatory ophthalmic eye drops from 9M India
-
Ophthalmology departments & eye hospitals
Ophthalmic surgery centres, cataract surgery programmes, government ophthalmology departments — anti-inflammatory eye drops are prescribed for every cataract surgery patient, making them among the highest-volume ophthalmic prescriptions.
-
Private label & contract manufacturing partners
Domestic ophthalmic brands manufacturing corticosteroid and NSAID eye drops through 9M India — Prednisolone Acetate 1% suspension is a technically demanding product with premium value.
-
International export buyers
All export markets — cataract surgery volumes are rising rapidly in developing countries, driving sustained demand for post-operative ophthalmic preparations.
Need WHO-GMP anti-inflammatory eye drops manufactured under your brand?
Share your requirement — molecule, concentration, pack size and target market. We confirm manufacturing capability, documentation and lead times within 24 hours.
-
WHO-GMP
Certified Facility -
In-House QC
-
Contract &
3PM Available -
DCGI
Approved
Ophthalmic categories
Ophthalmic formulations across 11 categories
We keep answer short
Frequently Asked Questions
Find answers to the most common questions about our products, services, pricing, and policies.
-
01
Yes. 9M India manufactures corticosteroid ophthalmic eye drops including Prednisolone Sodium Phosphate (0.5%, 1%), Dexamethasone Sodium Phosphate (0.1%), Betamethasone (0.1%) and Fluorometholone under WHO-GMP certified sterile ophthalmic conditions. All formulations are manufactured in classified cleanrooms with aseptic fill-finish and full batch documentation.
-
02
9M India manufactures ophthalmic NSAID eye drops including Ketorolac Tromethamine 0.4% (for post- operative pain and inflammation), Flurbiprofen 0.03% (intraoperative miosis prevention and post- operative inflammation), Diclofenac 0.1% and Indomethacin 0.1%. NSAIDs are increasingly preferred over steroids in certain ophthalmic indications due to their safety profile.
-
03
Corticosteroid eye drops (Prednisolone, Dexamethasone) are more potent anti-inflammatory agents used for significant intraocular and anterior segment inflammation — uveitis, post-operative inflammation, allergic eye disease. NSAID eye drops (Ketorolac, Flurbiprofen) are used for milder inflammation, cystoid macular oedema prevention post-cataract surgery and pain management. NSAIDs carry no risk of steroid-induced glaucoma or cataract, making them preferable for long-term use.
-
04
Yes. Prednisolone Sodium Phosphate 1% eye drops are the standard post-operative anti-inflammatory agent after cataract surgery and other intraocular procedures. 9M India manufactures this formulation for institutional surgical supply and government ophthalmic programmes. We can supply in institutional pack formats with complete GMP documentation including batch sterility test results.
-
05
Yes. 9M India manufactures combination anti-infective + anti-inflammatory eye drops including Ciprofloxacin + Dexamethasone, Gentamicin + Dexamethasone, Tobramycin + Dexamethasone and Moxifloxacin + Prednisolone. These combination formulations simplify post-operative management and are widely used in ophthalmic surgical settings.
-
06
Stability studies for anti-inflammatory ophthalmic formulations are conducted per ICH Zone IVb conditions (30°C/75% RH) — relevant for tropical and subtropical export markets. Data covers assay, pH, sterility, preservative content, particulate matter and colour over the 24-month shelf life. Full stability dossiers are available as part of the CTD/ACTD registration package.
-
07
Yes. Prednisolone 1% and Dexamethasone 0.1% eye drops are first-line treatments for anterior uveitis management. 9M India manufactures these formulations for institutional supply to hospital ophthalmology departments and can support large-volume procurement for national eye health programmes treating inflammatory ophthalmic conditions.
-
08
Documentation available includes WHO-GMP Certificate, DCGI Manufacturing Licence, CoPP, batch- wise CoA (sterility, particulate matter, pH, assay), ICH Zone IVb stability data and CTD/ACTD dossiers on request. Our team can assist export partners with dossier preparation for market registration in both semi-regulated and regulated markets.
